Cargando…
Febrile Neutropenia in a Patient with Non-Small Cell Lung Cancer Treated with the Immune-Checkpoint Inhibitor Nivolumab
Patient: Male, 57-year-old Final Diagnosis: Febrile neutropenia Symptoms: Fever Medication: Nivolumab Clinical Procedure: Chemotherapy Specialty: Oncology OBJECTIVE: Adverse events of drug therapy BACKGROUND: Nivolumab is a human IgG4 monoclonal antibody against human programmed cell death 1 (PD-1)....
Autores principales: | Hisamatsu, Yasushi, Morinaga, Ryotaro, Watanabe, Erina, Ohtani, Satoshi, Shirao, Kuniaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020738/ https://www.ncbi.nlm.nih.gov/pubmed/32018275 http://dx.doi.org/10.12659/AJCR.920809 |
Ejemplares similares
-
Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 Plus Bevacizumab
por: Otsu, Satoshi, et al.
Publicado: (2014) -
How I Treat Febrile Neutropenia
por: Nucci, Marcio
Publicado: (2021) -
Vesicocutaneous fistula formation during treatment with sunitinib malate: Case report
por: Watanabe, Koichiro, et al.
Publicado: (2010) -
Febrile neutropenia in chemotherapy treated small-cell lung cancer patients
por: Kukec, Renata Rezonja, et al.
Publicado: (2015) -
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)